@innophore

Catalophore based drug design, repurposing and large-scale virtual screenings for novel therapeutics and better enzymes.

 Austria
innophore.com
Joined December 2021
  • Tweets42
  • Following37
  • Followers189
20Media
And we are live! Watch our CEO, Christian C. Gruber, as he presents at the NVIDIA #GTC24. We’ve gathered in our office here in Graz to join the event online.
1
2
1
151
You can watch the presentation here: register.nvidia.com/flow/nvi…

GTC 2024: #1 AI Conference

Streamed online.

register.nvidia.com
92
Discover AI's impact on drug discovery with GPU-powered BioNeMo at #GTC24. On Mar 20, at 10am CET, learn how NVIDIA and @innophore innovate protein design, analyze biomolecular data, and apply insights through case studies in therapeutic breakthroughs. nvda.ws/4cebHfL
1
2
275
Our CEO, Christian Gruber, will be presenting at @NVIDIAGTC 2024 on Wednesday, March 20th from 10:00 AM to 10:50 AM CET (2:00 AM to 2:50 AM PDT). nvidia.com/gtc/session-catal… #GTC2024
1
1
81
His talk with David Ruau (Head of Strategic Alliances, Drug Discovery AI, NVIDIA), focuses on "Leveraging #AI for Enzyme and Drug Discovery." Join in to hear how Innophore’s technology can be utilized for #drugdiscovery and predicting side effects using our CavitOmiX platform.
48
Our COO, Bettina Nestl, will attend Bio-Europe Spring 2024 in Barcelona next week. Excited to connect and share insights on enzyme discovery, drug repurposing, and side-effect prediction! #BioEurope2024 #biotech #Biopharma #Innophore
2
79
Inspiring talks by A. Pritzel from @DeepMind and B. Nestl from @innophore about the potencial of AI in Biocatalysis #Biotrans2023 @HetBiocat
1
10
939
NVIDIA’s CEO Jensen Huang gave his keynote at @NVIDIAGTC 2023 conference, unveiling the latest advancements in generative AI, large language models, cloud computing, and more. We could not be more proud to be among the selected #NVIDIA #BioNeMo partners 🎉
1
1
6
514
You can watch the recorded GTC 2023 livestream here: lnkd.in/dj6MANX3
158
Behind the paper at @NaturePortfolio on designing variant-specific therapeutic SARS-CoV-2 decoys. The workflow features our #Catalophore™ Halos, deep #neuralnetworks and MD #simulations plus experimental validation. Read the full post here: go.nature.com/3QO7SUk
4
349
The year is off to an exciting start: Together with our partners @SignalChem, @awscloud, @acibGmbH, @MedUniGraz and @UniGraz we demonstrated the #AI pipeline to optimize variant-specific therapeutic SARS-CoV-2 ACE2 #decoys. nature.com/articles/s41598-0…

Optimizing variant-specific therapeutic SARS-CoV-2 decoys using deep-learning-guided molecular...

Scientific Reports - Optimizing variant-specific therapeutic SARS-CoV-2 decoys using deep-learning-guided molecular dynamics simulations

nature.com
1
1
3
386
This workflow combines our #Catalophore™ Halos with deep neural networks in conjunction with MD #simulations, validated in vitro and BSL3 neutralization assays. Reducing time-to-market for #biologics is critical, fast and efficient #leadoptimization is key for many future drugs.
1
149
#Antiviral drugs are one of the first lines of defense in fighting viral diseases. But is there a link between antiviral drugs and the evolution of the virus? Let's find out and read our recent publication here ⬇️ frontiersin.org/articles/10.… #SARSCoV2 #mutations
1
418
The innophore teams CavitOmiX for your #PyMol cavities #StructuralBiology @[email protected] #proteinstructureandfunction #enzymeengineering pymolwiki.org/index.php/Cavi…
2
12
1,764
Scientific publications often just report the hard facts, leaving out the story on what lead to the final findings. Take a look behind the scenes of one of our most recent publications and learn more about its creation in our blog post at @NaturePortfolio. go.nature.com/3NebrBk

Innophore's 3D point clouds provide a head start in monitoring emerging SARS-CoV-2 variants

The speed with which SARS-CoV-2 variants emerged left us little time to react. Rapid classification of new variants is a critical component of pandemic response, and structural bioinformatics methods...

communities.springernature.com
1
2
Grazer und Wiener Wissenschafter entwickeln eine Technologie, mit der sie die Mutation von Viren beobachten und voraussagen wollen. dlvr.it/SYJPwb
2
3
Grazer ForscherInnen entwickeln Technologie zur präzisen Einschätzung der Gefährlichkeit von Virus-Varianten 🔗 news.uni-graz.at/de/detail/a… #weworkfortomorrow 📷 @innophore, @luminous_lab #acib
5
1
14
Using a structural bioinformatics approach, researchers from @innophore, @UniGraz and @awscloud predict that Omicron spike receptor binding domain has a higher affinity to human ACE2 receptors, when compared to the wild type reference. nature.com/articles/s41598-0…

Structural bioinformatics analysis of SARS-CoV-2 variants reveals higher hACE2 receptor binding...

Scientific Reports - Structural bioinformatics analysis of SARS-CoV-2 variants reveals higher hACE2 receptor binding affinity for Omicron B.1.1.529 spike RBD compared to wild type reference

nature.com
1
6
Out latest publication in @SciReports is online! We are excited to share the details on how we use our Catalophore Halo technology to rapidly track changes in the RBD/hACE2 interface. Enjoy the short video summary and visit rdcu.be/cUn8E to read the full text. #COVID19
1
1
12
Recent changes in the mutational dynamics of the SARS-CoV-2 main-protease substantiate the danger of emerging resistance to antiviral drugs. #covid researchsquare.com/article/r…

Changes in the mutational dynamics of the SARS-CoV-2 main-protease substantiate the danger of...

The current coronavirus pandemic is being combated worldwide by nontherapeutic measures and massive vaccination programs. Nevertheless, therapeutic options such as SARS-CoV-2 main-protease (Mpro)...

researchsquare.com
2
2
Load more